We’re proud to share that Balthazar Raffy, PhD candidate at MSInsight, will be presenting an abstract at AI for Health in Paris on November 25th.
This abstract explores how Microsatellite Instability (MSI) can be leveraged to predict immune response in colorectal cancers, a critical component in identifying which patients are most likely to benefit from immunotherapy. By integrating genomic signals with advanced machine learning methods, this research aims to improve both stratification and treatment decision-making for clinicians.
This work reflects our broader mission at MSInsight: bringing together cutting-edge AI, genomic biomarkers, and clinical expertise to support more accurate, accessible precision oncology.
We look forward to contributing to the conversation in Paris and engaging with researchers pushing the boundaries of AI in healthcare.
🔗 Follow us for more updates on our research and upcoming presentations.
